Tri Locum Partners LP - Q3 2023 holdings

$313 Million is the total value of Tri Locum Partners LP's 61 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 108.5% .

 Value Shares↓ Weighting
AMGN NewAMGEN INC$28,886,325107,480
+100.0%
9.24%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDsponsored ads$26,855,509
+222.5%
2,632,893
+138.1%
8.59%
+177.4%
DXCM BuyDEXCOM INC$24,946,554
+274.8%
267,380
+416.2%
7.98%
+222.4%
ABBV NewABBVIE INC$21,548,263144,561
+100.0%
6.89%
SPY NewSPDR S&P 500 ETF TRtr unit$19,325,51645,208
+100.0%
6.18%
REGN SellREGENERON PHARMACEUTICALS$16,466,607
+11.0%
20,009
-3.1%
5.26%
-4.5%
CTLT BuyCATALENT INC$13,021,534
+49.4%
285,999
+42.3%
4.16%
+28.5%
NTRA BuyNATERA INC$12,159,679
+371.8%
274,795
+418.8%
3.89%
+305.8%
AVDL SellAVADEL PHARMACEUTICALS PLCsponsored adr$10,131,101
-40.9%
983,602
-5.4%
3.24%
-49.1%
AXSM SellAXSOME THERAPEUTICS INC$9,960,024
-30.7%
142,510
-28.8%
3.18%
-40.4%
NewGE HEALTHCARE TECHNOLOGIES I$8,968,352131,810
+100.0%
2.87%
WST SellWEST PHARMACEUTICAL SVSC INC$8,424,965
-45.7%
22,454
-44.6%
2.69%
-53.3%
PRAX SellPRAXIS PRECISION MEDICINES I$8,303,389
+47.8%
4,855,783
-0.6%
2.66%
+27.2%
SILK BuySILK RD MED INC$8,040,516
+24.7%
536,392
+170.2%
2.57%
+7.3%
ARGX NewARGENX SEsponsored adr$7,052,92414,346
+100.0%
2.26%
XFOR BuyX4 PHARMACEUTICALS INC$6,809,775
-14.4%
6,247,500
+52.4%
2.18%
-26.4%
IMGN BuyIMMUNOGEN INC$5,870,503
+4.5%
369,912
+24.2%
1.88%
-10.1%
XENE BuyXENON PHARMACEUTICALS INC$5,867,151
+529.2%
171,755
+609.1%
1.88%
+440.6%
ARCT NewARCTURUS THERAPEUTICS HLDGS$5,337,037208,886
+100.0%
1.71%
NewNUVALENT INC$5,218,882113,528
+100.0%
1.67%
VRNA BuyVERONA PHARMA PLCsponsored ads$5,184,639
+62.2%
318,076
+110.4%
1.66%
+39.6%
NewAMYLYX PHARMACEUTICALS INC$5,179,203282,862
+100.0%
1.66%
PMVP BuyPMV PHARMACEUTICALS INC$5,043,298
+408.6%
821,384
+418.5%
1.61%
+337.1%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$4,930,456
-17.9%
33,761
+29.8%
1.58%
-29.4%
BuyASTRIA THERAPEUTICS INC$4,462,035
+139.1%
598,128
+166.9%
1.43%
+105.6%
GKOS NewGLAUKOS CORP$4,231,30856,230
+100.0%
1.35%
ETNB Buy89BIO INC$3,853,376
+22.6%
249,571
+50.4%
1.23%
+5.5%
ALPN SellALPINE IMMUNE SCIENCES INC$3,595,632
+5.4%
314,029
-5.4%
1.15%
-9.3%
IMTX BuyIMMATICS N.V$3,531,599
+273.0%
304,974
+271.7%
1.13%
+220.7%
NewMOONLAKE IMMUNOTHERAPEUTICSclass a ord$3,038,10053,300
+100.0%
0.97%
AZN NewASTRAZENECA PLCsponsored adr$2,995,52644,234
+100.0%
0.96%
ISRG NewINTUITIVE SURGICAL INC$2,441,4988,353
+100.0%
0.78%
TVTX NewTRAVERE THERAPEUTICS INC$2,250,216251,702
+100.0%
0.72%
NewACELYRIN INC$1,582,177155,573
+100.0%
0.51%
NewKENVUE INCcall$1,104,40055,000
+100.0%
0.35%
MORF NewMORPHIC HLDG INC$838,64336,606
+100.0%
0.27%
GERN NewGERON CORP$807,892381,081
+100.0%
0.26%
VERA SellVERA THERAPEUTICS INCcl a$595,535
-65.9%
43,438
-60.1%
0.19%
-70.8%
HIG BuyHARTFORD FINL SVCS GROUP INC$248,185
+13.6%
3,500
+15.4%
0.08%
-2.5%
ANTM NewELEVANCE HEALTH INC$247,319568
+100.0%
0.08%
SDGR SellSCHRODINGER INC$235,093
-71.4%
8,316
-49.5%
0.08%
-75.4%
FEMY SellFEMASYS INC$228,283
+300.7%
76,605
-31.4%
0.07%
+247.6%
UPS NewUNITED PARCEL SERVICE INCcl b$221,8031,423
+100.0%
0.07%
YUM NewYUM BRANDS INC$218,7701,751
+100.0%
0.07%
APH SellAMPHENOL CORP NEWcl a$216,862
-2.9%
2,582
-1.8%
0.07%
-16.9%
ITW NewILLINOIS TOOL WKS INC$214,649932
+100.0%
0.07%
TEL NewTE CONNECTIVITY LTD$213,9541,732
+100.0%
0.07%
HSY NewHERSHEY CO$204,0821,020
+100.0%
0.06%
FAST NewFASTENAL CO$200,2013,664
+100.0%
0.06%
PEAK NewHEALTHPEAK PROPERTIES INC$187,54710,215
+100.0%
0.06%
RXRX NewRECURSION PHARMACEUTICALS INunit$171,90322,471
+100.0%
0.06%
PSEC NewPROSPECT CAP CORP$169,14027,957
+100.0%
0.05%
AM BuyANTERO MIDSTREAM CORP$161,107
+19.0%
13,448
+15.2%
0.05%
+4.0%
EDIT SellEDITAS MEDICINE INC$150,501
-95.1%
19,295
-94.8%
0.05%
-95.8%
RES NewRPC INC$107,91512,071
+100.0%
0.04%
IRWD NewIRONWOOD PHARMACEUTICALS INC$99,43910,326
+100.0%
0.03%
UAA NewUNDER ARMOUR INCcl a$88,39212,904
+100.0%
0.03%
SWN NewSOUTHWESTERN ENERGY CO$88,32013,693
+100.0%
0.03%
GCMG NewGCM GROSVENOR INC$79,37710,229
+100.0%
0.02%
NMRK NewNEWMARK GROUP INCcl a$73,41111,417
+100.0%
0.02%
JBLU BuyJETBLUE AWYS CORP$68,779
-44.1%
14,952
+7.6%
0.02%
-52.2%
UA ExitUNDER ARMOUR INCcl c$0-11,603
-100.0%
-0.03%
VTRS ExitVIATRIS INC$0-10,379
-100.0%
-0.04%
NRZ ExitRITHM CAPITAL CORP$0-13,531
-100.0%
-0.05%
KMI ExitKINDER MORGAN INC DEL$0-10,324
-100.0%
-0.07%
BRKB ExitBERKSHIRE HATHAWAY INC DELcl b new$0-588
-100.0%
-0.08%
CTAS ExitCINTAS CORP$0-414
-100.0%
-0.08%
CL ExitCOLGATE PALMOLIVE CO$0-2,701
-100.0%
-0.08%
PRU ExitPRUDENTIAL FINL INC$0-2,463
-100.0%
-0.08%
DOV ExitDOVER CORP$0-1,512
-100.0%
-0.08%
FGEN ExitFIBROGEN INCput$0-122,500
-100.0%
-0.12%
INBX ExitINHIBRX INC$0-15,268
-100.0%
-0.15%
ALDX ExitALDEYRA THERAPEUTICS INC$0-73,067
-100.0%
-0.23%
CBAY ExitCYMABAY THERAPEUTICS INC$0-70,588
-100.0%
-0.29%
COGT ExitCOGENT BIOSCIENCES INC$0-66,885
-100.0%
-0.29%
MRTX ExitMIRATI THERAPEUTICS INC$0-24,201
-100.0%
-0.32%
PTGX ExitPROTAGONIST THERAPEUTICS INC$0-33,750
-100.0%
-0.35%
CERE ExitCEREVEL THERAPEUTICS HLDNG I$0-41,292
-100.0%
-0.49%
MRSN ExitMERSANA THERAPEUTICS INC$0-428,307
-100.0%
-0.52%
ExitVENTYX BIOSCIENCES INC$0-57,800
-100.0%
-0.70%
ExitROIVANT SCIENCES LTD$0-202,406
-100.0%
-0.76%
MRUS ExitMERUS N V$0-101,691
-100.0%
-1.00%
ALNY ExitALNYLAM PHARMACEUTICALS INC$0-29,506
-100.0%
-2.08%
ExitSTEVANATO GROUP S P A$0-176,359
-100.0%
-2.12%
NARI ExitINARI MED INC$0-113,441
-100.0%
-2.45%
ILMN ExitILLUMINA INC$0-40,832
-100.0%
-2.84%
LEGN ExitLEGEND BIOTECH CORPsponsored ads$0-116,768
-100.0%
-3.00%
VRTX ExitVERTEX PHARMACEUTICALS INC$0-24,597
-100.0%
-3.22%
RETA ExitREATA PHARMACEUTICALS INCcl a$0-96,274
-100.0%
-3.65%
MDT ExitMEDTRONIC PLC$0-160,660
-100.0%
-5.26%
JNJ ExitJOHNSON & JOHNSON$0-127,362
-100.0%
-7.84%
LLY ExitLILLY ELI & COunit$0-54,369
-100.0%
-9.48%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FEMASYS INC10Q3 20230.5%
REGENERON PHARMACEUTICALS9Q3 202313.8%
LILLY ELI & CO9Q2 20239.5%
X4 PHARMACEUTICALS INC8Q3 20233.0%
XENON PHARMACEUTICALS INC8Q3 20232.4%
ARGENX SE7Q3 202312.8%
STEVANATO GROUP S P A7Q2 20235.8%
PROTAGONIST THERAPEUTICS INC7Q2 20237.1%
AVADEL PHARMACEUTICALS PLC7Q3 20236.4%
BELLUS HEALTH INC NEW7Q3 20224.3%

View Tri Locum Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-27
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16

View Tri Locum Partners LP's complete filings history.

Compare quarters

Export Tri Locum Partners LP's holdings